ConnectWise Manage is the deepest PSA platform in the MSP market (service boards, agreement-based billing, procurement workflows, and project management that go beyond what any competitor offers), but the implementation timeline, UI age, and opaque pricing make it a commitment, not a subscription.
Starting price: Contact vendor for exact pricing and packaging details.
Pricing model: Custom quote.
Deployment: Cloud.
Supported OS: Web.
Trial status: Trial not listed.
ConnectWise Manage is best for
Mid-size to large MSPs (10+ technicians) that need the deepest PSA in the market for service board automation, agreement-based billing, procurement workflows, and project management. Strongest when the MSP already runs ConnectWise Automate or ScreenConnect and wants the tightest RMM-PSA integration available.
Why ConnectWise Manage stands out
Feature depth is unmatched: service board automation, multi-tier agreement billing, procurement tracking, and project management workflows go beyond what Autotask, HaloPSA, Syncro, or SuperOps offer. The ConnectWise Automate integration is the tightest RMM-PSA pairing in the market: alerts flow into tickets, device context populates automatically, and billing ties back to managed agreements.
Main tradeoff with ConnectWise Manage
Implementation takes months, not weeks. Full deployment often requires ConnectWise professional services or a certified consultant. The UI shows its age and navigation efficiency is consistently criticized. Pricing requires direct sales engagement with no published rates.
Not ideal for
MSPs with fewer than 5 technicians, teams that need fast setup without consulting engagement, or organizations that want transparent pricing before committing to a sales cycle. Syncro, SuperOps, or Atera offer faster paths to a working PSA at lower complexity.
Typical buying motion
Enterprise-quoted through ConnectWise sales. Implementation typically requires ConnectWise professional services or a certified consultant. Plan for a 2-4 month onboarding timeline. No published pricing, no self-serve trial.